Cancer
Recent research on diagnostics and screening for cancer has made significant strides in identifying key regulators of gene expression and cellular signaling in cancer. Long non-coding RNAs (lncRNAs) are increasingly recognized as crucial modulators of chromatin structure, epigenetic remodeling, transcription, and signal transduction. A team of researchers from St. John&
Cancer
Research investigators have developed new antibody-gamma delta (gd) T cell conjugates that hold great promise in adoptive cell therapy, a promising approach to cancer treatment. The new conjugates are designed to enhance tumor-targeting efficiency and induce cancer cell pyroptosis. A team of researchers from Peking University conducted the study, which
Cancer
Research findings on artificial intelligence (AI) and machine learning (ML) applications in cancer immunotherapy have made significant progress in addressing the complex interplay between cancer and the immune system. A new report from the City of Hope National Medical Center in Duarte, California, highlights the potential of AI technologies in
Cancer
Researchers at Cedars-Sinai Medical Center have highlighted the challenges in using CAR-T cell therapy for treating solid tumors, including the unique immune microenvironment of these tumors. The study emphasizes the need for optimizing CAR-T cell functionality and adaptability to improve the therapy's effectiveness. Specifically, the research focuses on
Cancer
Researchers at the Indiana University School of Medicine have made a significant breakthrough in cancer treatment by reprogramming regulatory T cells (Tregs) to enhance antitumor immunity. According to a study published in Science Immunology, shifting the expression of FOXP3 from its full-length isoform to a short isoform with exon 2
Cancer
Recent research at Middle East University in Amman, Jordan, has elucidated the multifunctional role of short-chain fatty acids (SCFAs) in T lymphocyte biology, highlighting their therapeutic potential in cancer, infection, and autoimmune diseases. SCFAs, including acetate, propionate, and butyrate, have significant functions in host immune modulation, particularly in regulating T-cell
Cancer
A new study has shed light on the importance of upfront biomarker testing in patients with advanced non-small cell lung cancer (aNSCLC) and metastatic colorectal cancer (mCRC). The research, conducted by Genentech Inc., evaluated the landscape of biomarker testing coverage and reimbursement in state-regulated health plans. The findings suggest that
Cancer
New research from the Department of Oncology at the Affiliated Hospital of Soochow University in Changzhou, People's Republic of China, has shed light on the role of mitochondrial-related nuclear genes (MNGs) in gastric cancer (GC). By analyzing GC-related transcriptome data from the gene expression omnibus and cancer genome
Cancer
Research from Kwame Nkrumah University of Science and Technology has highlighted the potential of circulating free DNA (cfDNA) in detecting virus-associated cancers through the analysis of viral footprints. This approach offers transformative potential for early cancer detection, improving prognosis accuracy, and paving the way for innovative, non-invasive diagnostic tools and
Cancer
Researchers from Wuhan University in the People's Republic of China have developed a groundbreaking method for detecting circulating tumor cells (CTCs) in blood samples with high accuracy and speed. The method, which utilizes sialic acid recognition and microfluidic chip-single-cell inductively coupled plasma mass spectrometry (SC-ICP-MS), can quickly screen
Cancer
Researchers at Universidad Cientifica del Sur have made a breakthrough in gastric cancer treatment by discovering a potential therapeutic agent in the chloroform fraction of Dracontium spruceanum bulb. This natural compound, further referred to as DSBCl, has shown remarkable efficacy in modulating cancer stem cells (CSCs) and inhibiting tumor growth.
Cancer
Researchers have made significant progress in understanding the role of circulating tumor DNA (ctDNA) methylation in gastric cancer, a disease characterized by great tumor heterogeneity and genetic differences among subgroups. According to a recent study published in the World Journal of Gastrointestinal Oncology, ctDNA methylation has been linked to early
